Chimerix, Inc. (NASDAQ:CMRX) Q3 2024 Earnings Call November 7, 2024 8:30 AM ET
Company Participants
Will O’Connor – Investor Relations
Mike Andriole – President and Chief Executive Officer
Josh Allen – Chief Scientific Officer
Michelle LaSpaluto – Chief Financial Officer
Allen Melemed – Chief Medical Officer
Tom Riga – Chief Operating and Commercial Officer
Conference Call Participants
Maury Raycroft – Jefferies
Operator
Good morning, ladies and gentlemen and welcome to the Chimerix Third Quarter 2024 Earnings Conference Call. I would now like to introduce you to your host for today’s call, Will O’Connor from Stern Investor Relations. Please proceed.
Will O’Connor
Thank you, operator. Good morning, everyone and welcome to the Chimerix third quarter 2024 financial and operating results conference call. This morning, we issued a press release related to our third quarter operating update. You can access the press release in our Investors section of the website.
With me on today’s call are President and Chief Executive Officer, Mike Andriole; Chief Scientific Officer, Josh Allen; Chief Financial Officer, Michelle LaSpaluto; Chief Medical Officer, Allen Melemed; and Chief Operating and Commercial Officer, Tom Riga, for questions.
Before we begin, I’d like to remind you that the statements made on today’s call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties and other factors. These risks and uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. Please refer to our filings with the SEC for a more complete disclosure of these risks and uncertainties.
At this time, I’ll now turn the call over to President and Chief Executive Officer, Mike Andriole.
Mike Andriole
Thank you, Will. Good morning, everyone, and thanks for joining us. The third quarter was marked by continued execution across